I have done back of the envelope calcs of what the cash flow will be this year (not including capital investments/investing cash outflow or share buyback. However it includes income tax)
I've got about USD 950M more cashflow generated this FY compared to last.
This also includes likely income tax of about USD 795M this FY compared to USD 387M last FY (THis would be paid after year end)
I have income from iron ore sales as conservative 15% higher average USD 46 compared to USD 40 last year on output of 170m tonnes. We could do better than this as the weighted avg discount has narrowed to around 30% and this excluded West Pilbara Fines sales.
One off restructuring costs of USD 202 not relevant to this FY and likely interest savings of about USD 100 based on restructuring earlier this calendar year.
Depreciation and amortisation will affect the bottom line but not a cash flow item.
USD 950M more cashflow will bring total cashflow to around USD 3.1B
Profit after tax will be about USD 1.8B vs USD 0.98B last year
In AUD terms it would be about USD 2.3B or about 75c per share......
- Forums
- ASX - By Stock
- FMG
- Iron ore price
Iron ore price, page-8963
-
- There are more pages in this discussion • 44,023 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FMG (ASX) to my watchlist
(20min delay)
|
|||||
Last
$22.55 |
Change
0.445(2.01%) |
Mkt cap ! $69.53B |
Open | High | Low | Value | Volume |
$22.41 | $22.64 | $22.22 | $54.55M | 2.426M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 7445 | $22.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.55 | 883 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 7149 | 22.540 |
17 | 16318 | 22.530 |
11 | 3725 | 22.520 |
11 | 19669 | 22.510 |
13 | 6119 | 22.500 |
Price($) | Vol. | No. |
---|---|---|
22.550 | 719 | 11 |
22.560 | 10203 | 19 |
22.570 | 7132 | 24 |
22.580 | 6536 | 13 |
22.590 | 8494 | 13 |
Last trade - 14.08pm 15/07/2024 (20 minute delay) ? |
Featured News
FMG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online